4/16/2021  10:00:00 PM Chg. -0.44 Volume Bid10:14:59 PM Ask10:14:59 PM Market Capitalization Dividend Y. P/E Ratio
37.57CAD -1.16% 318,884
Turnover: 11.84 mill.
37.55Bid Size: 300 37.60Ask Size: 700 13.59 bill.CAD - -

Business description

Bausch Health Companies Inc. is a global company whose mission is to improve people's lives with health care products. Bausch develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
 

Management board & Supervisory board

CEO
Joseph C. Papa
Management board
Paul S. Herendeen (Advisor to the chairman and CEO ab 1.06.2021), Sam Eldessouky (an 1.06.2021), Barbara Purcell, Christina Ackermann, Dennis Asharin, Dr. Louis Yu, Dr. Tage Ramakrishna, Jeff Hartness, Joseph Gordon, Kelly Webber, Robert Spurr, Scott Hirsch, Thomas Appio
Supervisory board
Joseph C. Papa, Amy B. Wechsler, Andrew C. von Eschenbach, D. Robert Hale, Dr. Argeris N. Karabelas, John A. Paulson, Richard U. DeSchutter, Robert N. Power, Russel C. Robertson, Sarah B. Kavanagh, Thomas W. Ross
 

Company data

Name: Bausch Health Companies Inc.
Address: 2150 St. Elzéar Blvd. West,Laval, Quebec H7L 4A8, Canada
Phone: +1-514-744-6792
Fax: +1-514-744-6272
E-mail: -
Internet: https://www.bauschhealth.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: -
IPO date: -

Investor relations

Name: Arthur Shannon
IR phone: +1-514-856-3855
IR Fax: -
IR e-mail: arthur.shannon@bausc...lth.com arthur.shannon@bauschhealth.com

Company calendar

CW 19 | 5/4/2021 Interim Report 1st Quarter/3 Months
 

Main Shareholders

Freefloat
 
81.39%
FIL Ltd.
 
7.63%
Paulson & Co. Inc.
 
5.90%
VA Partners I, LLC
 
5.08%